Dihexa (5mg x 60 Capsules = 300mg)
$195.00
PRODUCT SHORT DESCRIPTION
Dihexa 5mg Capsules deliver a high-resolution, multi-unit oral research platform containing sixty 5000mcg encapsulated units of the angiotensin IV-derived nootropic peptide. This specialized solid-dose configuration is engineered strictly for investigating blood-brain barrier permeability, hepatocyte growth factor (HGF) receptor activation, and dendritic spinogenesis curves.
Introduction to the Neurogenic Secretagogue Matrix
Dihexa, biochemically classified as a synthetic, oligopeptide-derived small molecule ($\text{N-hexanoic-Tyr-Ile-NH}_2$), is an advanced molecular probe engineered to serve as a high-resolution catalyst in cognitive enhancement, neuroplasticity, and cellular longevity research. Developed as a highly stable analog of angiotensin IV, Dihexa acts as a specialized biochemical vehicle designed to cross the blood-brain barrier (BBB) with exceptional metabolic durability, overcoming the rapid enzymatic clearance that typically limits native neurological peptides.
Unlike standard lyophilized cakes or raw topical powders, this Dihexa 5mg Capsule configuration presents the neurogenic ligand in a solid-dose, encapsulated matrix (60 units per container). This multi-unit delivery form is engineered specifically for laboratories evaluating steady-state oral bioavailability thresholds, gastric stability profiles, and long-term receptor kinetics within central nervous system (CNS) models. At USA PEPTIDE SCIENCES, we supply these high-purity encapsulated units at a verified baseline purity, providing analytical biochemistry, molecular biology, and neurology institutions a reliable standard for mapping synaptic density and structural neural framework restoration.
Research Overview: HGF Activation and Synaptogenesis Kinetics
The primary scientific value of Dihexa 5mg capsules centers on its profound capacity to mimic, amplify, and accelerate the signaling cascades of native neurotrophic factors. By acting as a high-affinity small molecule agonist, Dihexa allows investigators to explore downstream dendritic branch variations and gene expression shifts in total isolation from large-protein delivery constraints.
Key areas of active scientific investigation utilizing Dihexa 5mg encapsulated units include:
-
Hepatocyte Growth Factor (HGF) Receptor Potentiation: Modeling the structural dimerization of the c-Met receptor. Dihexa binds directly to the HGF protein with ultra-high affinity ($\text{K}_d = 1.0 \text{ pM}$), facilitating its interaction with c-Met. This binding triggers tyrosine kinase autophosphorylation cascades, inducing cellular survival, migration, and structural tissue differentiation pathways.
-
Dendritic Spinogenesis and Synaptic Density: Investigating the morphological acceleration of neural networks. Studies focus on how Dihexa drives the formation of new dendritic spines and functional synapses (synaptogenesis) in hippocampal neuron cultures. Researchers analyze these curves to contrast Dihexa’s potency against endogenous brain-derived neurotrophic factor (BDNF).
-
Blood-Brain Barrier (BBB) Permeability Dynamics: Evaluating the structural properties that dictate CNS infiltration. Because Dihexa is an uncharged, hydrophobic small-molecule peptide derivative, it demonstrates exceptional passive transcellular diffusion across the blood-brain barrier, allowing researchers to track central neurotransmitter responses following peripheral administration.
-
Neuroprotective Attenuation and Memory Consolidation: Analyzing the biochemical pathways through which Dihexa mitigates chemical, traumatic, or neurodegenerative insults. In vivo models are utilized to measure the restoration of spatial learning, memory acquisition, and synaptic connectivity following induced neurological damage or targeted cellular senescence.
Quality Standards & Analytical Testing
At USA PEPTIDE SCIENCES, laboratory data integrity and compound reproducibility are the fundamental core of our manufacturing operations. Every single production lot of Dihexa 5mg Capsules undergoes a strict quality control validation protocol to eliminate compounding variables and experimental artifacts. We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm an absolute chemical purity profile of 99% or greater for the active compound within each capsule. This rigorous analytical validation verifies the exact molecular architecture, precise molecular weight, and correct spatial configuration while ensuring the total absence of heavy metals, residual synthesis reagents, or raw contaminants. A batch-specific Certificate of Analysis (COA) accompanies every order to guarantee absolute reproducibility.
Storage and Handling Requirements
To safeguard the complex structural integrity and prevent chemical breakdown of Dihexa 5mg Capsules, the container must be stored long-term in a cool, dry environment between 2°C and 8°C, completely shielded from direct light and excess ambient humidity. Desiccant packs included within the bottle must remain in place to protect the encapsulated units from premature moisture absorption. Prior to breaking the seal or introducing the capsules into an analytical workflow, the container should be allowed to acclimate to room temperature to avoid internal condensation.
Research Use Disclaimer
The compounds distributed by USA PEPTIDE SCIENCES, including Dihexa 5mg capsules, are designated strictly for laboratory research purposes only. Under no circumstances are these products approved or intended for human or veterinary consumption, direct clinical diagnostics, or therapeutic drug administration. All handling, measuring, and experimental evaluation must be conducted exclusively by qualified scientific professionals within a certified and monitored research facility.

Reviews
Clear filtersThere are no reviews yet.